This inventor holds 3 USPTO granted patents. Top assignees: Macronex, Inc., The University of North Carolina at Chapel Hill. Active years: 1996-1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1996-1997
Title: The Innovative Contributions of Henry Wong
Introduction
Henry Wong is a notable inventor based in Morrisville, NC (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that serve as inhibitors of inflammatory cytokines. With a total of 3 patents, his work has the potential to impact various therapeutic areas.
Latest Patents
Wong's latest patents include innovative compounds such as hydroxyalkylammonium-pyrimidines and nucleoside derivatives. These compounds have been identified as useful in the therapy of conditions like septic shock, cachexia, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, and AIDS. The preparation of these compounds typically involves the reaction of an iodo substituted nucleoside with the appropriately substituted hydroxyalkylamine. Additionally, he has developed novel N-substituted-(dihydroxyboryl)alkyl purine, indole, and pyrimidine derivatives, which also serve as inhibitors of inflammatory cytokines.
Career Highlights
Henry Wong has worked with esteemed institutions such as the University of North Carolina at Chapel Hill and Macronex, Inc. His research has focused on creating innovative solutions to complex medical challenges, showcasing his dedication to advancing healthcare through science.
Collaborations
Wong has collaborated with notable colleagues, including Bradley J Benson and Xiannong Chen. These partnerships have contributed to the successful development of his patented inventions.
Conclusion
Henry Wong's innovative work in the field of medicinal chemistry highlights his commitment to addressing significant health issues through his inventions. His contributions continue to pave the way for advancements in therapeutic treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile